About Rev Genomics
Rev Genomics is a company based in Oakland (United States) founded in 2015 by R J Cody Markelz and Bertrand Vick. Rev Genomics has raised $1.62 million across 2 funding rounds from investors including Y Combinator. The company has 5 employees as of December 31, 2022. Rev Genomics offers products and services including Genomics Data Pipeline, Advanced Tissue Culture, and Trait Stacking. Rev Genomics operates in a competitive market with competitors including Benson Hill, Cibus, Pairwise, Inari and Ceres, among others.
- Headquarter Oakland, United States
- Employees 5 as on 31 Dec, 2022
- Founders R J Cody Markelz, Bertrand Vick
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.62 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Seed
May 02, 2019
- Investors
-
Employee Count
5
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rev Genomics
Rev Genomics offers a comprehensive portfolio of products and services, including Genomics Data Pipeline, Advanced Tissue Culture, and Trait Stacking.
Processes genomic data to optimize plant breeding efficiency.
Creates stable phenotypes for high-value crop development.
Stacks traits to produce superior, disease-resistant cultivars.
People of Rev Genomics
Unlock access to complete
Unlock access to complete
Funding Insights of Rev Genomics
Rev Genomics has successfully raised a total of $1.62M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Rev Genomics
Rev Genomics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Rev Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rev Genomics
Investment portfolio details for Rev Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rev Genomics
Detailed financials for Rev Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rev Genomics Comparisons
Peer comparison for Rev Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rev Genomics
Rev Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benson Hill, Cibus, Pairwise, Inari and Ceres, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of plant-based food ingredients
|
|
| Locked | Locked | Locked |
Gene editing solutions are provided for agriculture.
|
|
| Locked | Locked | Locked |
New crop varieties are developed using gene-editing for agrigenomics.
|
|
| Locked | Locked | Locked |
Breeding technology is provided by Inari to design seeds.
|
|
| Locked | Locked | Locked |
Beers are produced and branded by Ceres in Italy.
|
|
| Locked | Locked | Locked |
Production and distribution of GM and non-GMO seeds and other farm inputs
|
Detailed competitors of Rev Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rev Genomics
Complete news archive for Rev Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rev Genomics
Rev Genomics was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Rev Genomics is headquartered in Oakland, United States. It is registered at Oakland, California, United States.
Bertrand Vick is the current CEO of Rev Genomics. They have also founded this company.
Rev Genomics is a funded company, having raised a total of $1.62M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Rev Genomics is 5.
Rev Genomics was founded in 2015 and is headquartered in Oakland, United States. Services in genetic engineering for plant crops are offered within the agricultural sector. Whole genome selection, advanced tissue culture, molecular genetics, and metabolite analytics are employed to develop modified crops. Operations center on enhancing crop traits through these scientific methods.
Rev Genomics's top competitors include Benson Hill, Cibus and Inari.
Rev Genomics offers Genomics Data Pipeline, Advanced Tissue Culture, and Trait Stacking.
Rev Genomics has 1 investor. Key investors include Y Combinator.